Journal of Comprehensive Pediatrics

Published by: Kowsar

Role of Kobayashi Risk Scoring for Determining Refractory Kawasaki Disease

Seyed-Reza Raeeskarami 1 , 2 , Fatemeh Tahghighi 1 , Amir Hossien Ziaee Bigdeli 1 , Raheleh Assari 3 , Vahid Ziaee Array , Yahya Aghighi 1 , 4 and Payman Sadeghi 1 , 2 , 5 , *
Authors Information
1 Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 Bahrami Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 Vali-Asr Hospital, Imam Khomeini Complex, Tehran University of Medical Science,Tehran, Iran
4 Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
5 Department of Pediatrics, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Comprehensive Pediatrics: November 2018, 9 (4); e67116
  • Published Online: November 13, 2018
  • Article Type: Research Article
  • Received: February 4, 2018
  • Revised: September 22, 2018
  • Accepted: October 7, 2018
  • DOI: 10.5812/compreped.67116

To Cite: Raeeskarami S, Tahghighi F, Ziaee Bigdeli A H , Assari R, Ziaee V, et al. Role of Kobayashi Risk Scoring for Determining Refractory Kawasaki Disease, J Compr Ped. 2018 ; 9(4):e67116. doi: 10.5812/compreped.67116.

Abstract
Copyright © 2018, Journal of Comprehensive Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Council on Cardiovascular Disease in the Young; Committee on Rheumatic Fever Endocarditis and Kawasaki Disease; American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation. 2001;103(2):335-6. doi: 10.1161/01.cir.103.2.335. [PubMed: 11208699].
  • 2. Sepahi MA, Miri R, Ahmadi HT. Association of sterile pyuria and coronary artery aneurysm in Kawasaki syndrome. Acta Med Iran. 2011;49(9):606-11. [PubMed: 22052144].
  • 3. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: From the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239-45. doi: 10.2188/jea.JE20140089. [PubMed: 25716368]. [PubMed Central: PMC4341001].
  • 4. Malekzadeh I, Ziaee V, Sadrosadat T, Moardinejad MH, Sayadpour-Zanjani K. Kawasaki disease and peripheral gangrene in infancy. Iran J Ped. 2015;25(6). doi: 10.5812/ijp.3309.
  • 5. Singh S, Kansra S. Kawasaki disease. Natl Med J India. 2005;18(1):20-4. [PubMed: 15835487].
  • 6. Nabavizadeh SH, Safari M, Amin R. Hair loss as a sign of Kawasaki disease. Iran J Allergy Asthma Immunol. 2006;5(4):199-200. [PubMed: 17237574].
  • 7. Ozen S, Orhan D. Renal involvement in children with vasculitis. Berlin, Heidelberg: Springer; 2014.
  • 8. Han RK, Sinclair B, Newman A, Silverman ED, Taylor GW, Walsh P, et al. Recognition and management of Kawasaki disease. CMAJ. 2000;162(6):807-12. [PubMed: 10750471]. [PubMed Central: PMC1231277].
  • 9. Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, et al. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin. Int J Cardiol. 2016;214:209-15. doi: 10.1016/j.ijcard.2016.03.017. [PubMed: 27070994].
  • 10. Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831-5. doi: 10.1016/j.jpeds.2010.10.031. [PubMed: 21168857]. [PubMed Central: PMC3075321].
  • 11. Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, et al. Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child. 2015;100(4):366-8. doi: 10.1136/archdischild-2014-307397. [PubMed: 25670405].
  • 12. Fu PP, Du ZD, Pan YS. Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatr Infect Dis J. 2013;32(8):e319-23. doi: 10.1097/INF.0b013e31828e887f. [PubMed: 23446442].
  • 13. Saffar MJ, Reshidighader F. Kawasaki disease in East Mazandaran, Islamic Republic of Iran, 1997-2002. East Mediterr Health J. 2005;11(1-2):28-35. [PubMed: 16532668].
  • 14. Marcdante K, Kliegmen R, Macdante K, Jenson H, Behramn R, Robert M, et al. Nelson essentials of pediatrics. 5th ed. Philadelphia: WB Saunders; 2006.
  • 15. Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, et al. Incomplete Kawasaki disease in patients younger than 1 year of age: A possible inherent risk factor. Eur J Pediatr. 2009;168(2):157-62. doi: 10.1007/s00431-008-0722-1. [PubMed: 18478263].
  • 16. Kiani A, Rafieyian S, Roodpeyma S, Sefidgarnia M. The relationship between coronary artery aneurysm and QT interval dispersion in acute phase of Kawasaki disease. Iran J Pediatr. 2011;21(2):220-4. [PubMed: 23056791]. [PubMed Central: PMC3446150].
  • 17. Shin J, Lee H, Eun L. Verification of current risk scores for Kawasaki disease in Korean children. J Korean Med Sci. 2017;32(12):1991-6. doi: 10.3346/jkms.2017.32.12.1991. [PubMed: 29115081]. [PubMed Central: PMC5680498].
  • 18. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606-12. doi: 10.1161/CIRCULATIONAHA.105.592865. [PubMed: 16735679].
  • 19. Zhao CN, Du ZD, Gao LL. Corticosteroid therapy might be associated with the development of coronary aneurysm in children with Kawasaki disease. Chin Med J (Engl). 2016;129(8):922-8. doi: 10.4103/0366-6999.179801. [PubMed: 27064036]. [PubMed Central: PMC4831526].
  • 20. Deng YC, Wang X, Tang XC, Huang CZ, Yang J, Mo LY. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children]. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17(9):927-31. Chinese. [PubMed: 26412172].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments